Personalized, Transdiagnostic Approach to Preventative Mental Health
Status unconfirmed · Not applicable
Conditions studied: Mental Health, Mental Disorders, Delivery of Health Care, Self-Assessment, Diagnosis, Psychiatric
In brief
This study is investigating the self-report adherence and assessment completion rates when presented with a transdiagnostic, partial assessment multiple times a day when compared with a monotopic, complete assessment once a day. Specifically, the investigators are testing the hypothesis that the personalization of diagnostic assessment topics and timing will lead to improved self-report regiment adherence rates, assessment completion rates, and total assessments completed during the study period. The study does not test the efficacy of the personalized assessments as a diagnostic instrument, there is no clinical decision support provided to clinicians during this study, and there is no treatment provided during this study.
Key facts
- Study ID
- NCT03946319
- Run by
- Introspect Health
- People needed
- 50
- Starts
- 2019-05-01
- Expected to finish
- 2019-08-01
- Last updated by the study team
- 2019-05-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 18 or older
- English fluency
- US citizen
- California resident
- Eligible to receive mental healthcare in the state of California
- Primary user of a smartphone device
- Daily access to Internet and email
- Meets a minimum level of 2.51 or higher on a self-rated technology use scale based on the average score of three Likert-style questions
- Willing to answer questions about themselves pertaining to physical and mental wellness throughout the Research Period
You may not qualify if…
- Undergoing care for condition requiring emergent treatment or hospitalization, including but not limited to: current or recent (within 3 months) acute manic or major depressive episode, clear and current suicidal risk, current or recent (within 3 months) history of substance abuse or drug dependence
- Undergoing active treatment for a condition wherein the additional burden of performing daily assessments may interfere with their pre-existing treatment regiment, cause undue anxiety, or risk inflammation of pre-existing issues
- Undergoing active treatment using a treatment modality that may adversely interact with research study participation such as psychopharmaceuticals affecting memory and cognition, therapeutic digital detox, or similar treatments
- Has ever participated in a Research Study testing the efficacy of transdiagnostic assessments, transdiagnostic interventions, or Internet-based CBT
- Additionally, patients on psychotropic medications are only eligible to be included while they maintain a stable dosage of their medication; if their medication dosage needs to change for any reason during the course of the Research Study, they would be required to withdraw from the study.
Where it is running
- California Institute of Integral Studies — San Francisco, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.